Peptide Encyclopedia / GHRP-6
EncyclopediaGHRP-6 is a growth hormone-releasing peptide and ghrelin-receptor agonist that triggers pituitary GH release and a strong rise in hunger. Human data stay limited to early-phase and animal studies, it holds no FDA approval, and it stays restricted under FDA Category 2. Educational only, not medical advice.
| Category | Growth Hormone |
| Half-life | 15-60 minutes |
| Regulatory status | Not FDA-approved. |
A growth hormone-releasing peptide / ghrelin-receptor agonist that stimulates pituitary GH release and strongly increases hunger.
~15-60 minutes; short and uncertain.
Not FDA-approved. On FDA Category 2; as of 2026 reporting, expected to REMAIN restricted. Prohibited by WADA.
Pronounced increased appetite, water retention, possible cortisol/prolactin rise, injection-site reactions. Long-term safety not established.
Limited human data; mostly early-phase/animal studies and anecdotal use.
Log every dose and injection site, get the reconstitution and units math automatically, follow your cycle, and record how you feel, then export a provider report. GHRP-6 tracker, free to start.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. GHRP-6 may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.